AUROBINDO PHARMA LTD.
NSE : AUROPHARMABSE : 524804ISIN
CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse
: Aurobindo
BSE1152.6521.5 (+1.9 % )
PREV CLOSE (Rs.) 1131.15
OPEN PRICE (Rs.) 1135.65
BID PRICE (QTY) 1151.35 (16 )
OFFER PRICE (QTY) 1152.45 (52 )
VOLUME 29162
TODAY'S LOW / HIGH (Rs.)
52 WK LOW / HIGH (Rs.)
NSE1151.95 20.65 (+1.83 % )
PREV CLOSE(Rs.) 1131.30
OPEN PRICE (Rs.) 1137.00
BID PRICE (QTY) 1151.95 (31 )
OFFER PRICE (QTY) 1152.25 (62 )
VOLUME 1130485
TODAY'S LOW / HIGH(Rs.)
52 WK LOW / HIGH (Rs.)
Cah Flow
(Rs in Million)
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|
| Profit Before Tax | 26125.00 | 33727.40 | 73435.90 | 37430.40 | 30913.50 |
| Adjustment | 15864.70 | 13441.30 | -16626.40 | 10911.70 | 8139.50 |
| Changes In working Capital | -10949.80 | 15578.00 | -10666.50 | 3079.10 | -14845.00 |
| Cash Flow after changes in Working Capital | 31039.90 | 62746.70 | 46143.00 | 51421.20 | 24208.00 |
| Cash Flow from Operating Activities | 23867.50 | 50164.80 | 33290.50 | 43812.80 | 16509.70 |
| Cash Flow from Investing Activities | -39777.50 | -32115.60 | 5986.90 | -15676.40 | -29025.90 |
| Cash Flow from Financing Activities | 18144.10 | -29692.70 | -13649.40 | -19471.80 | 19190.60 |
| Net Cash Inflow / Outflow | 2234.10 | -11643.50 | 25628.00 | 8664.60 | 6674.40 |
| Opening Cash & Cash Equivalents | 41625.10 | 53299.10 | 27468.20 | 18755.80 | 12099.40 |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | NA | NA | NA | NA | NA |
| Cash & Cash Equivalent of Subsidiaries under liquidations | 64.10 | -32.50 | 224.10 | NA | NA |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | NA | NA | NA | NA | NA |
| Effect of Foreign Exchange Fluctuations | -0.60 | 2.00 | -21.20 | 47.80 | -18.00 |
| Closing Cash & Cash Equivalent | 43922.70 | 41625.10 | 53299.10 | 27468.20 | 18755.80 |
